accreditation and certification

intended audience

This activity was developed for physicians, pharmacists, and nursing professionals practicing in long-term care settings.

learning objectives

Upon completion of this activity, participants should be better able to:

Describe the impact of constipation for their patients in long-term care settings

Communicate with their patients to elicit information regarding bowel habits

Interpret diagnostic data to facilitate the appropriate diagnosis of constipation

Utilize efficacy and safety data for currently available constipation therapeutic
options to optimize treatment of their patients and enhance their quality of life

accreditation and certification

The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Annenberg Center designates this educational activity for a maximum of 1 AMA PRA Category 1 Credittm. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program has been developed according to the ACPE Criteria for Quality and is assigned ACPE Universal Program #797-000-08-002-H04-P. This program is designated for up to 1.0 contact hour (0.1 CEUs) of continuing pharmacy education credit.

Annenberg Center for Health Sciences is approved as a provider of nurse practitioner continuing education by the American Academy of Nurse Practitioners. Provider #040207. The Annenberg Center designates this program for 1 contact hour of continuing education

Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
A maximum of 1 contact hour may be earned for successful completion of this activity.

There is no charge for this activity. Statements of Credit will be provided by mail following activity participation, and upon completion and return of the evaluation form to the Annenberg Center for Health Sciences.

disclosure

It is the policy of the Annenberg Center to ensure fair balance, independence, objectivity, and scientific rigor in all programming. All faculty participating in sponsored programs are expected to identify and reference off-label product use and disclose any significant relationship with those supporting the activity or any others whose products or services are discussed.

In accordance with the Accreditation Council for Continuing Medical Education Standards, parallel documents from other accrediting bodies, and Annenberg Center policy, the following disclosures have been made:

John F. Johanson, MD
Consultant:	Salix Pharmaceuticals, Inc. Sucampo Pharmaceuticals, Inc. Takeda Pharmaceuticals, Inc. Theravance
Speakers Bureau:	Salix Pharmaceuticals, Inc. Sucampo Pharmaceuticals, Inc. Takeda Pharmaceuticals, Inc.
Joseph G. Ouslander, MD
Research Support:	Sepracor, Inc.
Consultant:	Pfizer, Inc.
Speakers Bureau:	Pfizer, Inc.
Nicholas J. Talley, MD, PhD
Financial Support:	Dynogen Pharmaceuticals, Inc. GlaxoSmithKline Novartis Pharmaceuticals Takeda Pharmaceuticals, Inc. Tioga Pharmaceuticals, Inc.
Consultant:	AccreditEd Addex Pharmaceuticals Annenberg Publishing Astellas Pharma US, Inc. AstraZeneca Callisto Pharmaceuticals Conexus Ferring Pharmaceuticals F-Network, Ltd. Interactive Forums, Inc. Lexicon Genetics, Inc. McNeil Consumer Medscape from WebMD Metabolic Pharmaceuticals, Ltd. MGI Pharma, Inc. Microbia Novartis Pharmaceiticals Oakstone Publishing Pharma Frontiers, Ltd. Procter & Gamble Pharmaceuticals Salix Pharmacueticals
Joel Legunn (medical writer)
	Nothing to disclose

All staff at the Annenberg Center for Health Sciences at Eisenhower have nothing to disclose.

The faculty for this activity have disclosed that there will be no discussion about the use of products for non-FDA approved applications.

The ideas and opinions presented in this educational activity are those of the faculty and do not necessarily reflect the views of the Annenberg Center and/or its agents. As in all educational activities, we encourage the practitioners to use their own judgment in treating and addressing the needs of each individual patient, taking into account that patient's unique clinical situation. The Annenberg Center disclaims all liability and cannot be held responsible for any problems that may arise from participating in this activity or following treatment recommendations presented.

This activity is supported by an independent educational grant from Sucampo Pharmaceuticals, Inc. and Takeda Pharmaceuticals North America, Inc.

This activity is an enduring material and consists of a Web activity. Successful completion is achieved by reading and viewing the materials, reflecting on its implications in your practice, and completing the assessment component.

The estimated time to complete the activity is 1 hour.

This activity was originally released in August 2008 and is eligible for credit through July 2009.

If you need reasonable, special accommodations or have questions about access to any of our activities, please contact Connie Brown by phone at 800-321-3690, by fax at 760-773-4550, or by E-mail to . All requests must be received at least 14 days in advance of the intended activity start date.